People
-
CDMO MedPharm has announced the appointment of former DPT Laboratories executive Eugene Ciolfi as President and CEO, replacing Co-Founder Andy Muddle, who will remain “in an ambassadorial role.” Ciolfi was most recently VP and Site… Read more . . .
-
Insmed Incorporated has announced that its Chairman of the Board Donald Hayden, Jr is stepping down as chairman and will be replaced by Insmed President and CEO Will Lewis. Hayden, who served as chairman for… Read more . . .
-
Intranasal drug developer Impel NeuroPharma has announced the appointment of former Allergan VP of External Science & Innovation Ellen A. Lubman as Chief Business Officer. Her previous experience also includes stints at Kadmon Pharmaceuticals and… Read more . . .
-
Belgian soft mist inhaler company Softhale has announced the appointment of Nevan Charles Elam to its board of directors. Currently Chairman and CEO of Rezolute, Elam was formerly Senior VP and Head of the Pulmonary… Read more . . .
-
Cambridge Design Partnership (CDP) has announced the appointment of OINDP device designer David Harris to head up the company’s respiratory drug delivery development business. According to CDP, the company is entering “a new phase of… Read more . . .
-
Dance Biopharm has announced the appointment of Phillips-Medisize President and CEO Matt Jennings to its board of directors. Phillips-Medisize is developing a connected version of Dance’s insulin soft mist inhaler device. Jennings joined Phillips-Medisize as… Read more . . .
-
US-based pharmaceutical supply services firm Experic is expanding its focus with the appointment of DPI expert Justin Lacombe as Director of Pharmaceutical Development and Manufacturing Services and the announcement that the company has leased a… Read more . . .
-
Inhaled insulin developer Dance Biopharm has announced the appointment of former Novoclem Pharmaceuticals President and CEO Anne Whitaker as a Director and CEO as of October 1st, 2018. In addition to founding and heading up… Read more . . .
-
Roivant, which recently acquired Patara Pharma’s cromolyn sodium inhalation solution for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF), has launched a company called Respivant to develop the drug. The new… Read more . . .
-
Device developer Iconovo AB has announced the appointment of Mikael Ekström as its new VP, Development effective September 1, 2018. Ekström held various positions at AstraZeneca over a period of almost 30 years, most recently… Read more . . .
Featured event:
Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 14-October 15: Advancing Bioequivalence Frameworks for Inhalation and Nasal Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods, Rockville, MD, USA
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden
October 21-October 22: MVIC Symposium, Lund, Sweden
October 28-October 30: Deutches Aerosol Therapie Symposium (DATS), Marburg, Germany
November 10-November 11: Rescon Europe 2026, Porto, Portugal